Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
This weakens zonules, leading to bilateral lens dislocation in most cases, prevalent from infancy to later years
Steady-state blood levels are typically reached by week 4-5 of treatment
Unique to Retatrutide this third receptor is why it produces stronger results than dual-agonist medicines
Technical Information Compound Name: Retatrutide Peptide Classification: Triple Hormone Receptor Agonist (GLP-1 / GIP / Glucagon Receptor Agonist) Molecular Formula: CHNO Appearance: White to off-white lyophilized powder Solubility: Typically soluble in bacteriostatic water or suitable research-grade diluents Research Category: Metabolic and multi-receptor pathway research peptide Common Research Areas GLP-1, GIP, and glucagon receptor signaling Glucose-homeostasis investigations Appetite and satiety-related research Adipose and energy-balance studies Metabolic and obesity-related investigations Cardiometabolic and endocrine-signaling pathways For Laboratory and Research Use Only Not for human consumption or therapeutic use
Current evidence supports the use of systemic antioxidants for management of selected cases of male infertility [175]
US$ 20.37
US$ 20.94
US$ 29.94
US$ 20.25
/v1774461588/website/2178382825.jpg?w=1060&h=600&quality=75&mode=crop&scale=both)
